ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-14O18665
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dermatological Non Steroidal Anti Inflammatory Drugs Market Research Report 2024
BUY CHAPTERS

Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2024

Code: QYRE-Auto-14O18665
Report
November 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Verona Pharma
Lead Chemical
Sato Pharmaceutical
Arcutis
Genzyme
GlaxoSmithKline PLC
Merck KGaA
Pfizer Inc
Roche
MSD
Huadong Medicine
Shapuaisi

Dermatological Non-Steroidal Anti-Inflammatory Drugs Market

The global Dermatological Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of anti-inflammatory drugs that do not contain steroidal structures and are widely used in antipyretic, analgesic, anti-inflammatory and anti-rheumatic treatments. In dermatology, nonsteroidal anti-inflammatory drugs (NSAIDs) reduce symptoms such as pain, swelling, and fever by inhibiting inflammatory mediators in the body.
North American market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs include Verona Pharma, LEAD CHEMICAL, Sato Pharmaceutical, Arcutis, Genzyme Co., GlaxoSmithKline PLc, Merck KGaA, Pfizer Inc., Roche, MSD, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermatological Non-Steroidal Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Non-Steroidal Anti-Inflammatory Drugs.
The Dermatological Non-Steroidal Anti-Inflammatory Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Non-Steroidal Anti-Inflammatory Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Report

Report Metric Details
Report Name Dermatological Non-Steroidal Anti-Inflammatory Drugs Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Verona Pharma, LEAD CHEMICAL, Sato Pharmaceutical, Arcutis, Genzyme Co., GlaxoSmithKline PLc, Merck KGaA, Pfizer Inc., Roche, MSD, Huadong Medicine, Shapuaisi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dermatological Non-Steroidal Anti-Inflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dermatological Non-Steroidal Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dermatological Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The main players in the Dermatological Non-Steroidal Anti-Inflammatory Drugs Market are Verona Pharma, LEAD CHEMICAL, Sato Pharmaceutical, Arcutis, Genzyme Co., GlaxoSmithKline PLc, Merck KGaA, Pfizer Inc., Roche, MSD, Huadong Medicine, Shapuaisi

What are the Application segmentation covered in the Dermatological Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The Applications covered in the Dermatological Non-Steroidal Anti-Inflammatory Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Dermatological Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The Types covered in the Dermatological Non-Steroidal Anti-Inflammatory Drugs Market report are Ketoconazole, Phthalin Butan, Ketotifen, Loratadine, Prednisone, Cyclosporine A, Tacrolimus, Others

Recommended Reports

Dermatology Drug Markets

NSAIDs & Analgesics

Topical & Anti-Inflammatory

1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Overview
1.1 Product Definition
1.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs by Type
1.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Ketoconazole
1.2.3 Phthalin Butan
1.2.4 Ketotifen
1.2.5 Loratadine
1.2.6 Prednisone
1.2.7 Cyclosporine A
1.2.8 Tacrolimus
1.2.9 Others
1.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs by Application
1.3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Estimates and Forecasts
1.4.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue 2019-2030
1.4.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales 2019-2030
1.4.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Competition by Manufacturers
2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Product Type & Application
2.7 Global Key Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
2.8 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Competitive Situation and Trends
2.8.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dermatological Non-Steroidal Anti-Inflammatory Drugs Players Market Share by Revenue
2.8.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Scenario by Region
3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2019-2030
3.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2019-2024
3.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2025-2030
3.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2019-2030
3.3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2019-2024
3.3.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2025-2030
3.4 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.4.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.4.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.5.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.5.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.7.1 Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.7.3 Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2030)
4.1.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2019-2024)
4.1.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2025-2030)
4.1.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2030)
4.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2019-2030)
4.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2019-2024)
4.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2025-2030)
4.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2030)
5.1.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2019-2024)
5.1.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2025-2030)
5.1.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2030)
5.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2019-2030)
5.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2019-2024)
5.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2025-2030)
5.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Verona Pharma
6.1.1 Verona Pharma Company Information
6.1.2 Verona Pharma Description and Business Overview
6.1.3 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.1.5 Verona Pharma Recent Developments/Updates
6.2 LEAD CHEMICAL
6.2.1 LEAD CHEMICAL Company Information
6.2.2 LEAD CHEMICAL Description and Business Overview
6.2.3 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.2.5 LEAD CHEMICAL Recent Developments/Updates
6.3 Sato Pharmaceutical
6.3.1 Sato Pharmaceutical Company Information
6.3.2 Sato Pharmaceutical Description and Business Overview
6.3.3 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.3.5 Sato Pharmaceutical Recent Developments/Updates
6.4 Arcutis
6.4.1 Arcutis Company Information
6.4.2 Arcutis Description and Business Overview
6.4.3 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.4.5 Arcutis Recent Developments/Updates
6.5 Genzyme Co.
6.5.1 Genzyme Co. Company Information
6.5.2 Genzyme Co. Description and Business Overview
6.5.3 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.5.5 Genzyme Co. Recent Developments/Updates
6.6 GlaxoSmithKline PLc
6.6.1 GlaxoSmithKline PLc Company Information
6.6.2 GlaxoSmithKline PLc Description and Business Overview
6.6.3 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.6.5 GlaxoSmithKline PLc Recent Developments/Updates
6.7 Merck KGaA
6.7.1 Merck KGaA Company Information
6.7.2 Merck KGaA Description and Business Overview
6.7.3 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Pfizer Inc.
6.8.1 Pfizer Inc. Company Information
6.8.2 Pfizer Inc. Description and Business Overview
6.8.3 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.8.5 Pfizer Inc. Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 MSD
6.10.1 MSD Company Information
6.10.2 MSD Description and Business Overview
6.10.3 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.10.5 MSD Recent Developments/Updates
6.11 Huadong Medicine
6.11.1 Huadong Medicine Company Information
6.11.2 Huadong Medicine Description and Business Overview
6.11.3 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.11.5 Huadong Medicine Recent Developments/Updates
6.12 Shapuaisi
6.12.1 Shapuaisi Company Information
6.12.2 Shapuaisi Description and Business Overview
6.12.3 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
6.12.5 Shapuaisi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Chain Analysis
7.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Production Mode & Process
7.4 Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales and Marketing
7.4.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Channels
7.4.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors
7.5 Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers
8 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Dynamics
8.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Trends
8.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Drivers
8.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Challenges
8.4 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Verona Pharma
Lead Chemical
Sato Pharmaceutical
Arcutis
Genzyme
GlaxoSmithKline PLC
Merck KGaA
Pfizer Inc
Roche
MSD
Huadong Medicine
Shapuaisi
List of Tables
 Table 1. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units) of Key Manufacturers (2019-2024)
 Table 5. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Dermatological Non-Steroidal Anti-Inflammatory Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Non-Steroidal Anti-Inflammatory Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024) & (Units)
 Table 18. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2025-2030) & (Units)
 Table 20. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (Units)
 Table 27. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (Units)
 Table 28. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (Units)
 Table 32. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (Units)
 Table 33. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2019-2024) & (Units)
 Table 37. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2025-2030) & (Units)
 Table 38. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (Units)
 Table 42. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (Units)
 Table 43. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2019-2024) & (Units)
 Table 47. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2025-2030) & (Units)
 Table 48. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units) by Type (2019-2024)
 Table 51. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units) by Type (2025-2030)
 Table 52. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units) by Application (2019-2024)
 Table 61. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units) by Application (2025-2030)
 Table 62. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Verona Pharma Company Information
 Table 71. Verona Pharma Description and Business Overview
 Table 72. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 74. Verona Pharma Recent Developments/Updates
 Table 75. LEAD CHEMICAL Company Information
 Table 76. LEAD CHEMICAL Description and Business Overview
 Table 77. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 79. LEAD CHEMICAL Recent Developments/Updates
 Table 80. Sato Pharmaceutical Company Information
 Table 81. Sato Pharmaceutical Description and Business Overview
 Table 82. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 84. Sato Pharmaceutical Recent Developments/Updates
 Table 85. Arcutis Company Information
 Table 86. Arcutis Description and Business Overview
 Table 87. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 89. Arcutis Recent Developments/Updates
 Table 90. Genzyme Co. Company Information
 Table 91. Genzyme Co. Description and Business Overview
 Table 92. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 94. Genzyme Co. Recent Developments/Updates
 Table 95. GlaxoSmithKline PLc Company Information
 Table 96. GlaxoSmithKline PLc Description and Business Overview
 Table 97. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 99. GlaxoSmithKline PLc Recent Developments/Updates
 Table 100. Merck KGaA Company Information
 Table 101. Merck KGaA Description and Business Overview
 Table 102. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 104. Merck KGaA Recent Developments/Updates
 Table 105. Pfizer Inc. Company Information
 Table 106. Pfizer Inc. Description and Business Overview
 Table 107. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 109. Pfizer Inc. Recent Developments/Updates
 Table 110. Roche Company Information
 Table 111. Roche Description and Business Overview
 Table 112. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 114. Roche Recent Developments/Updates
 Table 115. MSD Company Information
 Table 116. MSD Description and Business Overview
 Table 117. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 119. MSD Recent Developments/Updates
 Table 120. Huadong Medicine Company Information
 Table 121. Huadong Medicine Description and Business Overview
 Table 122. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 124. Huadong Medicine Recent Developments/Updates
 Table 125. Shapuaisi Company Information
 Table 126. Shapuaisi Description and Business Overview
 Table 127. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product
 Table 129. Shapuaisi Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors List
 Table 133. Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers List
 Table 134. Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Trends
 Table 135. Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Drivers
 Table 136. Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Challenges
 Table 137. Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dermatological Non-Steroidal Anti-Inflammatory Drugs
 Figure 2. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Type: 2023 & 2030
 Figure 4. Ketoconazole Product Picture
 Figure 5. Phthalin Butan Product Picture
 Figure 6. Ketotifen Product Picture
 Figure 7. Loratadine Product Picture
 Figure 8. Prednisone Product Picture
 Figure 9. Cyclosporine A Product Picture
 Figure 10. Tacrolimus Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 13. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Application: 2023 & 2030
 Figure 14. Hospital
 Figure 15. Clinic
 Figure 16. Others
 Figure 17. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size (2019-2030) & (US$ Million)
 Figure 19. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (2019-2030) & (Units)
 Figure 20. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 21. Dermatological Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
 Figure 22. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Manufacturers in 2023
 Figure 23. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers in 2023
 Figure 24. Global 5 and 10 Largest Dermatological Non-Steroidal Anti-Inflammatory Drugs Players: Market Share by Revenue in Dermatological Non-Steroidal Anti-Inflammatory Drugs in 2023
 Figure 25. Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 26. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 27. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
 Figure 28. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2030)
 Figure 29. United States Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Canada Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
 Figure 32. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2030)
 Figure 33. Germany Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. France Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. U.K. Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Italy Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Russia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2019-2030)
 Figure 39. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2019-2030)
 Figure 40. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Japan Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. South Korea Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. India Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Australia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. China Taiwan Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Southeast Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
 Figure 48. Mexico Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Brazil Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Argentina Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Colombia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2019-2030)
 Figure 53. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2019-2030)
 Figure 54. Turkey Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. UAE Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. Global Sales Market Share of Dermatological Non-Steroidal Anti-Inflammatory Drugs by Type (2019-2030)
 Figure 58. Global Revenue Market Share of Dermatological Non-Steroidal Anti-Inflammatory Drugs by Type (2019-2030)
 Figure 59. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 60. Global Sales Market Share of Dermatological Non-Steroidal Anti-Inflammatory Drugs by Application (2019-2030)
 Figure 61. Global Revenue Market Share of Dermatological Non-Steroidal Anti-Inflammatory Drugs by Application (2019-2030)
 Figure 62. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 63. Dermatological Non-Steroidal Anti-Inflammatory Drugs Value Chain
 Figure 64. Dermatological Non-Steroidal Anti-Inflammatory Drugs Production Process
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Topical Non Steroidal Anti Inflammatory Drugs Market Research Report 2024
Non steroidal Anti inflammatory Drugs NSAID Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dermatological Medicine Market Research Report 2024
Global Dermatological OTC Drugs Market Research Report 2024
Global Dermatitis Drugs Market Research Report 2024
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Non Steroidal Anti Inflammatory API Market Research Report 2025
Global Dermatological Disorders Medications Market Research Report 2024
Global Inflammatory Skin Diseases Drugs Market Research Report 2024
Global Nonnarcotic Analgesics Market Research Report 2025
Global Non melanoma Skin Cancer Drugs Market Research Report 2024
Global Non opioid Analgesics Market Research Report 2024
Global Prescription Dermatological Medications Market Research Report 2024
Global Noncontact Dermatoscopes Market Research Report 2024
Global Atopic Dermatitis Medication Market Research Report 2025
Prescription Dermatological Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Skin Medicine Market Research Report 2024
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Moderate to Severe Atopic Dermatitis Treatment Drugs Market Research Report 2024
Global OTC Topical Skin Medicine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions